Buy this Article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Authors

  1. Aschenbrenner, Diane S. MS, RN

Abstract

* The antiarrythmic drug dronedarone (Multaq) shouldn't be used to treat permanent atrial fibrillation. A large clinical trial found that dronedarone increased the rates of death, stroke, and hospitalization for heart failure in this population.

 

* Dronedarone is approved to treat nonpermanent atrial fibrillation; at this time it may still be used for this indication.